 Home > Medical News > Latest Medical News > Announcement of Phase I study of Hebo Pharma's new-generation anti-CTLA-4 antibody HBM4003

Announcement of Phase I study of Hebo Pharma's new-generation anti-CTLA-4 antibody HBM4003

 Last Update: 2021-10-23
 Source: Internet
 Author: User

Tags

gas treatment

phase definition

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 13, Harmonicare announced that its self-developed product HBM4003 has achieved positive results in a phase I dose-climbing clinical trial for patients with advanced solid tumors in Australia

The Phase I study data is the first clinical evidence of a new generation of anti-CTLA-4 fully human monoclonal heavy chain antibody (HCAb) in solid tumors

The Phase I study is an open-label, multi-center study conducted in subjects with advanced solid tumors.

Main results of the Phase I study

(I) The 4 Australian centers of the Phase I study enrolled 20 subjects with advanced solid tumors.

(Ii) HBM4003 therapy shows good safety

(Iii) It is recommended to use 0.

(Iv) A total of 15 patients underwent post-treatment tumor assessment

(V) For patients with hepatocellular carcinoma with partial remission, prolonged clinical benefit was observed after stopping treatment

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.